{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T10:20:57Z","timestamp":1769595657509,"version":"3.49.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,1,5]],"date-time":"2019-01-05T00:00:00Z","timestamp":1546646400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med Imaging"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s12880-018-0303-3","type":"journal-article","created":{"date-parts":[[2019,1,5]],"date-time":"2019-01-05T07:30:56Z","timestamp":1546673456000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["Screening mammography for second breast cancers in women with history of early-stage breast cancer: factors and causes associated with non-detection"],"prefix":"10.1186","volume":"19","author":[{"given":"Yoo Kyung","family":"Yeom","sequence":"first","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3478-6721","authenticated-orcid":false,"given":"Eun Young","family":"Chae","sequence":"additional","affiliation":[]},{"given":"Hak Hee","family":"Kim","sequence":"additional","affiliation":[]},{"given":"Joo Hee","family":"Cha","sequence":"additional","affiliation":[]},{"given":"Hee Jung","family":"Shin","sequence":"additional","affiliation":[]},{"given":"Woo Jung","family":"Choi","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2019,1,5]]},"reference":[{"key":"303_CR1","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/S0960-9776(03)00129-2","volume":"13","author":"PM Webb","year":"2004","unstructured":"Webb PM, Cummings MC, Bain CJ, Furnival CM. Changes in survival after breast cancer: improvements in diagnosis or treatment? Breast. 2004;13:7\u201314.","journal-title":"Breast"},{"key":"303_CR2","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1002\/ijc.11226","volume":"106","author":"M Sant","year":"2003","unstructured":"Sant M, Allemani C, Capocaccia R, et al. Stage at diagnosis is a key explanation of differences in breast cancer survival across Europe. Int J Cancer. 2003;106:416\u201322.","journal-title":"Int J Cancer"},{"key":"303_CR3","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1001\/jama.2011.188","volume":"305","author":"N Houssami","year":"2011","unstructured":"Houssami N, Abraham LA, Miglioretti DL, et al. Accuracy and outcomes of screening mammography in women with a personal history of early-stage breast cancer. JAMA. 2011;305:790\u20139.","journal-title":"JAMA"},{"key":"303_CR4","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.1001\/jamaoncol.2017.1256","volume":"3","author":"N Cho","year":"2017","unstructured":"Cho N, Han W, Han BK, et al. Breast cancer screening with mammography plus ultrasonography or magnetic resonance imaging in women 50 years or younger at diagnosis and treated with breast conservation therapy. JAMA Oncol. 2017;3:1495\u2013502.","journal-title":"JAMA Oncol"},{"key":"303_CR5","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1016\/j.ejso.2013.05.004","volume":"39","author":"MJ Sangen van der","year":"2013","unstructured":"van der Sangen MJ, Poortmans PM, Scheepers SW, et al. Prognosis following local recurrence after breast conserving treatment in young women with early breast cancer. Eur J Surg Oncol. 2013;39:892\u20138.","journal-title":"Eur J Surg Oncol"},{"key":"303_CR6","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1007\/s10549-008-0023-4","volume":"114","author":"WL Lu","year":"2009","unstructured":"Lu WL, Jansen L, Post WJ, Bonnema J, Van de Velde JC, De Bock GH. Impact on survival of early detection of isolated breast recurrences after the primary treatment for breast cancer: a meta-analysis. Breast Cancer Res Treat. 2009;114:403\u201312.","journal-title":"Breast Cancer Res Treat"},{"key":"303_CR7","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1200\/JCO.2012.45.9859","volume":"31","author":"JL Khatcheressian","year":"2013","unstructured":"Khatcheressian JL, Hurley P, Bantug E, et al. Breast cancer follow-up and management after primary treatment: American Society of Clinical Oncology clinical practice guideline update. J Clin Oncol. 2013;31:961\u20135.","journal-title":"J Clin Oncol"},{"key":"303_CR8","doi-asserted-by":"publisher","first-page":"281","DOI":"10.7150\/jca.8016","volume":"5","author":"EJ Schneble","year":"2014","unstructured":"Schneble EJ, Graham LJ, Shupe MP, et al. Current approaches and challenges in early detection of breast cancer recurrence. J Cancer. 2014;5:281\u201390.","journal-title":"J Cancer"},{"key":"303_CR9","unstructured":"National Comprehensive Cancer Network. NCCN guidline Breast cancer, version 2. \n                    https:\/\/www.nccn.org\/professionals\/physician_gls\/default.aspx\n                    \n                  . Published 2017."},{"key":"303_CR10","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1148\/radiol.12111458","volume":"264","author":"VA Arasu","year":"2012","unstructured":"Arasu VA, Joe BN, Lvoff NM, et al. Benefit of semiannual ipsilateral mammographic surveillance following breast conservation therapy. Radiology. 2012;264:371\u20137.","journal-title":"Radiology"},{"key":"303_CR11","doi-asserted-by":"publisher","first-page":"R3","DOI":"10.1186\/bcr3595","volume":"16","author":"L Domingo","year":"2014","unstructured":"Domingo L, Salas D, Zubizarreta R, et al. Tumor phenotype and breast density in distinct categories of interval cancer: results of population-based mammography screening in Spain. Breast Cancer Res. 2014;16:R3.","journal-title":"Breast Cancer Res"},{"key":"303_CR12","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1158\/1055-9965.EPI-12-1208-T","volume":"22","author":"N Houssami","year":"2013","unstructured":"Houssami N, Abraham LA, Kerlikowske K, et al. Risk factors for second screen-detected or interval breast cancers in women with a personal history of breast cancer participating in mammography screening. Cancer Epidemiol Biomark Prev. 2013;22:946\u201361.","journal-title":"Cancer Epidemiol Biomark Prev"},{"key":"303_CR13","doi-asserted-by":"publisher","first-page":"673","DOI":"10.7326\/M14-1465","volume":"162","author":"K Kerlikowske","year":"2015","unstructured":"Kerlikowske K, Zhu W, Tosteson AN, et al. Identifying women with dense breasts at high risk for interval cancer: a cohort study. Ann Intern Med. 2015;162:673\u201381.","journal-title":"Ann Intern Med"},{"key":"303_CR14","doi-asserted-by":"publisher","first-page":"226","DOI":"10.7326\/M15-0971","volume":"164","author":"HD Nelson","year":"2016","unstructured":"Nelson HD, O'Meara ES, Kerlikowske K, Balch S, Miglioretti D. Factors associated with rates of false-positive and false-negative results from digital mammography screening: an analysis of registry data. Ann Intern Med. 2016;164:226\u201335.","journal-title":"Ann Intern Med"},{"key":"303_CR15","unstructured":"American College of Radiology, BI-RADS Committee. ACR BI-RADS atlas : breast imaging reporting and data system, 5th ed. Reston, Va: American College of Radiology, 2013."},{"key":"303_CR16","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1148\/radiol.2461062173","volume":"246","author":"S Schrading","year":"2008","unstructured":"Schrading S, Kuhl CK. Mammographic, US, and MR imaging phenotypes of familial breast cancer. Radiology. 2008;246:58\u201370.","journal-title":"Radiology"},{"key":"303_CR17","unstructured":"A. Berg W, Mendelson E, Le-Petross H, Zhang Z, Marques H, Adams A. Reasons for failed cancer detection in the ACRIN 6666 screening protocol: mammography, US, and MRI. \n                    http:\/\/archive.rsna.org\/2011\/11006596.html\n                    \n                  . Published 2011."},{"key":"303_CR18","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1148\/radiol.12112074","volume":"264","author":"SR Hoff","year":"2012","unstructured":"Hoff SR, Abrahamsen AL, Samset JH, Vigeland E, Klepp O, Hofvind S. Breast cancer: missed interval and screening-detected cancer at full-field digital mammography and screen-film mammography-- results from a retrospective review. Radiology. 2012;264:378\u201386.","journal-title":"Radiology"},{"key":"303_CR19","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1148\/radiol.13130724","volume":"270","author":"MS Bae","year":"2014","unstructured":"Bae MS, Moon WK, Chang JM, et al. Breast cancer detected with screening US: reasons for nondetection at mammography. Radiology. 2014;270:369\u201377.","journal-title":"Radiology"},{"key":"303_CR20","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1148\/radiol.2262011634","volume":"226","author":"DM Ikeda","year":"2003","unstructured":"Ikeda DM, Birdwell RL, O'Shaughnessy KF, Brenner RJ, Sickles EA. Analysis of 172 subtle findings on prior normal mammograms in women with breast cancer detected at follow-up screening. Radiology. 2003;226:494\u2013503.","journal-title":"Radiology"},{"key":"303_CR21","doi-asserted-by":"publisher","first-page":"1933","DOI":"10.1002\/1097-0142(19930915)72:6<1933::AID-CNCR2820720623>3.0.CO;2-N","volume":"72","author":"JA Dijck van","year":"1993","unstructured":"van Dijck JA, Verbeek AL, Hendriks JH, Holland R. The current detectability of breast cancer in a mammographic screening program. A review of the previous mammograms of interval and screen-detected cancers. Cancer. 1993;72:1933\u20138.","journal-title":"Cancer"},{"key":"303_CR22","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1007\/978-1-60327-492-0_15","volume":"472","author":"NF Boyd","year":"2009","unstructured":"Boyd NF, Martin LJ, Rommens JM, et al. Mammographic density: a heritable risk factor for breast cancer. Methods Mol Biol. 2009;472:343\u201360.","journal-title":"Methods Mol Biol"},{"key":"303_CR23","doi-asserted-by":"publisher","first-page":"10","DOI":"10.7326\/0003-4819-155-1-201107050-00003","volume":"155","author":"JT Schousboe","year":"2011","unstructured":"Schousboe JT, Kerlikowske K, Loh A, Cummings SR. Personalizing mammography by breast density and other risk factors for breast cancer: analysis of health benefits and cost-effectiveness. Ann Intern Med. 2011;155:10\u201320.","journal-title":"Ann Intern Med"},{"key":"303_CR24","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1001\/jama.1996.03540010035027","volume":"276","author":"K Kerlikowske","year":"1996","unstructured":"Kerlikowske K, Grady D, Barclay J, Sickles EA, Ernster V. Effect of age, breast density, and family history on the sensitivity of first screening mammography. JAMA. 1996;276:33\u20138.","journal-title":"JAMA"},{"key":"303_CR25","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1148\/radiology.184.3.1509041","volume":"184","author":"RE Bird","year":"1992","unstructured":"Bird RE, Wallace TW, Yankaskas BC. Analysis of cancers missed at screening mammography. Radiology. 1992;184:613\u20137.","journal-title":"Radiology"},{"key":"303_CR26","unstructured":"Yang T-IJ. Prognostic implications of patients with mammographically occult, early stage breast cancer \n                    http:\/\/elischolar.library.yale.edu\/ymtdl\/1606\n                    \n                  . Published 2011."},{"key":"303_CR27","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1634\/theoncologist.2011-0127","volume":"17","author":"R Macfarlane","year":"2012","unstructured":"Macfarlane R, Seal M, Speers C, et al. Molecular alterations between the primary breast cancer and the subsequent locoregional\/metastatic tumor. Oncologist. 2012;17:172\u20138.","journal-title":"Oncologist"},{"key":"303_CR28","doi-asserted-by":"publisher","first-page":"4317","DOI":"10.7314\/APJCP.2015.16.10.4317","volume":"16","author":"RS Nemr Esmail El","year":"2015","unstructured":"El Nemr Esmail RS, El Farouk Abdel-Salam LO, Abd El Ellah MM. Could the breast prognostic biomarker status change during disease progression? An immunohistochemical comparison between primary tumors and synchronous nodal metastasis. Asian Pac J Cancer Prev. 2015;16:4317\u201321.","journal-title":"Asian Pac J Cancer Prev"},{"key":"303_CR29","first-page":"1425","volume":"21","author":"S Ilgun","year":"2016","unstructured":"Ilgun S, Sarsenov D, Erdogan Z, et al. Receptor discordance rate and its effects on survival in primary and recurrent breast cancer patients. J BUON. 2016;21:1425\u201332.","journal-title":"J BUON"},{"key":"303_CR30","doi-asserted-by":"publisher","first-page":"219","DOI":"10.3348\/kjr.2015.16.2.219","volume":"16","author":"JH Yoon","year":"2015","unstructured":"Yoon JH, Kim MJ, Kim EK, Moon HJ. Imaging surveillance of patients with breast cancer after primary treatment: current recommendations. Korean J Radiol. 2015;16:219\u201328.","journal-title":"Korean J Radiol"}],"container-title":["BMC Medical Imaging"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12880-018-0303-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12880-018-0303-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12880-018-0303-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,1,4]],"date-time":"2020-01-04T19:08:49Z","timestamp":1578164929000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmedimaging.biomedcentral.com\/articles\/10.1186\/s12880-018-0303-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1,5]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["303"],"URL":"https:\/\/doi.org\/10.1186\/s12880-018-0303-3","relation":{},"ISSN":["1471-2342"],"issn-type":[{"value":"1471-2342","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,1,5]]},"assertion":[{"value":"27 September 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 December 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 January 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was approved by the institutional review board of Asan Medical Center (No. 2017\u20130440), and the need for informed consent was waived due to the retrospective design of the study.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"2"}}